CIM Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$569K Buy
920
+459
+100% +$284K 0.11% 167
2025
Q1
$292K Hold
461
0.07% 182
2024
Q4
$328K Buy
461
+2
+0.4% +$1.43K 0.1% 179
2024
Q3
$483K Sell
459
-9
-2% -$9.46K 0.14% 125
2024
Q2
$492K Sell
468
-3
-0.6% -$3.15K 0.15% 127
2024
Q1
$453K Hold
471
0.14% 153
2023
Q4
$414K Sell
471
-200
-30% -$176K 0.13% 153
2023
Q3
$552K Sell
671
-11
-2% -$9.05K 0.2% 106
2023
Q2
$490K Buy
682
+2
+0.3% +$1.44K 0.17% 122
2023
Q1
$559K Buy
680
+112
+20% +$92K 0.21% 108
2022
Q4
$410K Sell
568
-10
-2% -$7.22K 0.16% 132
2022
Q3
$398K Buy
578
+24
+4% +$16.5K 0.18% 119
2022
Q2
$327K Sell
554
-3
-0.5% -$1.77K 0.14% 153
2022
Q1
$389K Sell
557
-505
-48% -$353K 0.13% 149
2021
Q4
$671K Sell
1,062
-19
-2% -$12K 0.2% 103
2021
Q3
$654K Sell
1,081
-6
-0.6% -$3.63K 0.21% 102
2021
Q2
$607K Sell
1,087
-18
-2% -$10.1K 0.19% 114
2021
Q1
$523K Sell
1,105
-40
-3% -$18.9K 0.16% 127
2020
Q4
$553K Buy
+1,145
New +$553K 0.18% 108
2020
Q1
Sell
-996
Closed -$374K 228
2019
Q4
$374K Hold
996
0.15% 141
2019
Q3
$276K Sell
996
-105
-10% -$29.1K 0.1% 251
2019
Q2
$345K Buy
1,101
+42
+4% +$13.2K 0.13% 199
2019
Q1
$435K Hold
1,059
0.17% 161
2018
Q4
$396K Sell
1,059
-44
-4% -$16.5K 0.17% 150
2018
Q3
$446K Hold
1,103
0.16% 174
2018
Q2
$381K Sell
1,103
-32
-3% -$11.1K 0.13% 224
2018
Q1
$391K Sell
1,135
-28
-2% -$9.65K 0.13% 214
2017
Q4
$437K Sell
1,163
-18
-2% -$6.76K 0.15% 195
2017
Q3
$528K Sell
1,181
-67
-5% -$30K 0.19% 151
2017
Q2
$613K Sell
1,248
-1,276
-51% -$627K 0.22% 119
2017
Q1
$978K Buy
+2,524
New +$978K 0.34% 59
2015
Q2
Sell
-1,935
Closed -$874K 275
2015
Q1
$874K Buy
+1,935
New +$874K 0.38% 97
2014
Q3
Sell
-4,412
Closed -$1.25M 212
2014
Q2
$1.25M Sell
4,412
-124
-3% -$35K 0.63% 56
2014
Q1
$1.36M Sell
4,536
-105
-2% -$31.5K 0.63% 40
2013
Q4
$1.28M Buy
4,641
+330
+8% +$90.8K 0.65% 51
2013
Q3
$1.35M Buy
+4,311
New +$1.35M 0.8% 37